Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1994 2
1996 2
1998 1
1999 3
2003 2
2007 1
2009 2
2010 1
2012 1
2015 1
2017 1
2018 1
2019 2
2020 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Retrospective Analysis of Clinical Genetic Testing in Pediatric Primary Dilated Cardiomyopathy: Testing Outcomes and the Effects of Variant Reclassification.
Quiat D, Witkowski L, Zouk H, Daly KP, Roberts AE. Quiat D, et al. J Am Heart Assoc. 2020 Jun 2;9(11):e016195. doi: 10.1161/JAHA.120.016195. Epub 2020 May 27. J Am Heart Assoc. 2020. PMID: 32458740 Free PMC article.
Background Genetic testing in pediatric primary dilated cardiomyopathy (DCM) patients has identified numerous disease-causing variants, but few studies have evaluated genetic testing outcomes in this population in the context of patient and familial clinical …
Background Genetic testing in pediatric primary dilated cardiomyopathy (DCM) patients has identified numerous disease-c …
Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy.
Calore C, Cacciavillani L, Boffa GM, Silva C, Tiso E, Marra MP, Bacchiega E, Corbetti F, Iliceto S. Calore C, et al. J Cardiovasc Med (Hagerstown). 2007 Oct;8(10):821-9. doi: 10.2459/JCM.0b013e3280101e3c. J Cardiovasc Med (Hagerstown). 2007. PMID: 17885521
OBJECTIVES: Differentiation between primary dilated cardiomyopathy and ischemic cardiomyopathy has an important clinical significance. ...
OBJECTIVES: Differentiation between primary dilated cardiomyopathy and ischemic cardiomyopathy has an important clinica …
Differentiation between primary dilated cardiomyopathy and ischemic cardiomyopathy based on right ventricular performance.
Iskandrian AS, Helfeld H, Lemlek J, Lee J, Iskandrian B, Heo J. Iskandrian AS, et al. Am Heart J. 1992 Mar;123(3):768-73. doi: 10.1016/0002-8703(92)90518-z. Am Heart J. 1992. PMID: 1539529
The differentiation of primary dilated cardiomyopathy from ischemic cardiomyopathy, though important, is difficult clinically and may require coronary angiography or metabolic imaging. ...
The differentiation of primary dilated cardiomyopathy from ischemic cardiomyopathy, though important, is difficult clin …
Left Ventricular Layer-Specific Myocardial Strains in Children with Recovered Primary Dilated Cardiomyopathy: What Lies Beneath the Iceberg?
Maher E, Elshehaby W, El Amrousy D, El Razaky O. Maher E, et al. Pediatr Cardiol. 2020 Jan;41(1):101-107. doi: 10.1007/s00246-019-02228-7. Epub 2019 Nov 3. Pediatr Cardiol. 2020. PMID: 31680221
We aimed to detect residual cardiac dysfunction-if any-in children with recovered primary dilated cardiomyopathy (DCM) by using the left ventricular (LV) layer-specific myocardial strains. ...
We aimed to detect residual cardiac dysfunction-if any-in children with recovered primary dilated cardiomyopathy (DCM) …
Examination of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) as a Potential Biomarker in Heart Failure Patients.
Sarszegi Z, Szabo D, Gaszner B, Konyi A, Reglodi D, Nemeth J, Lelesz B, Polgar B, Jungling A, Tamas A. Sarszegi Z, et al. J Mol Neurosci. 2019 Jul;68(3):368-376. doi: 10.1007/s12031-017-1025-7. Epub 2018 Jan 20. J Mol Neurosci. 2019. PMID: 29353438
Therefore, the aim of the present study was to measure the alterations of blood PACAP levels in chronic heart failure caused by primary dilated cardiomyopathy or ischemic cardiomyopathy and to examine the possible relationship between serum levels of PACAP, N …
Therefore, the aim of the present study was to measure the alterations of blood PACAP levels in chronic heart failure caused by primary …
Clinicopathological features of fatal cardiomyopathy in childhood: an autopsy series.
Roberts SE, Pryce JW, Weber MA, Malone M, Ashworth MT, Sebire NJ. Roberts SE, et al. J Paediatr Child Health. 2012 Aug;48(8):675-80. doi: 10.1111/j.1440-1754.2012.02450.x. Epub 2012 Apr 19. J Paediatr Child Health. 2012. PMID: 22515160

Heart weight of cardiomyopathy cases was significantly greater than those with normal hearts (P < 0.001), and 77% had heart weights above the 95th percentile of the normal expected range for age, including all of those over 1 year age. Of cardiomyopathy cases, 50% were prim

…

Heart weight of cardiomyopathy cases was significantly greater than those with normal hearts (P < 0.001), and 77% had heart weights above

…
PACAP-38 and PAC1 Receptor Alterations in Plasma and Cardiac Tissue Samples of Heart Failure Patients.
Szabó D, Sárszegi Z, Polgár B, Sághy É, Reglődi D, Tóth T, Onódi Z, Leszek P, Varga ZV, Helyes Z, Kemény Á, Ferdinandy P, Tamás A. Szabó D, et al. Int J Mol Sci. 2022 Mar 28;23(7):3715. doi: 10.3390/ijms23073715. Int J Mol Sci. 2022. PMID: 35409075 Free PMC article.
PACAP-38 levels of myocardial tissues were lower in all end-stage HF patients and lower PAC1 receptor levels were detected in the primary dilated cardiomyopathy group compared to the controls. We conclude that PACAP-38 and PAC1 expression correlates with some …
PACAP-38 levels of myocardial tissues were lower in all end-stage HF patients and lower PAC1 receptor levels were detected in the primary …
HLA class II polymorphisms in Tunisian patients with dilated cardiomyopathy.
Mahjoub S, Mehri S, Ghazouani E, Ouarda F, Boussada R, Zaroui A, Mechmeche R, Hammami M, Ben Arab S. Mahjoub S, et al. Tissue Antigens. 2010 Jun;75(6):679-83. doi: 10.1111/j.1399-0039.2009.01432.x. Epub 2010 Jan 28. Tissue Antigens. 2010. PMID: 20136773
The present study was the first report to evaluate the relationship between class II major histocompatibility complex (MHC) genes (HLA-DRB1 and HLA-DQB1) and the genetic susceptibility to primary dilated cardiomyopathy (DCM) in Tunisian patients. The human le …
The present study was the first report to evaluate the relationship between class II major histocompatibility complex (MHC) genes (HLA-DRB1 …
Cardiac resynchronization therapy and cardiac sympathetic function.
Martignani C, Diemberger I, Nanni C, Biffi M, Ziacchi M, Boschi S, Corzani A, Fanti S, Sambuceti G, Boriani G. Martignani C, et al. Eur J Clin Invest. 2015 Aug;45(8):792-9. doi: 10.1111/eci.12471. Epub 2015 Jul 3. Eur J Clin Invest. 2015. PMID: 26036750
MATERIALS AND METHODS: Ten patients (six males, age 68 10 years) with primary dilated cardiomyopathy were studied before and after resynchronization (acutely and after 3 months), from a clinical and echocardiographic point of view. ...
MATERIALS AND METHODS: Ten patients (six males, age 68 10 years) with primary dilated cardiomyopathy were studied befor …
Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes.
Pelliccia A, Maron BJ, Culasso F, Spataro A, Caselli G. Pelliccia A, et al. JAMA. 1996 Jul 17;276(3):211-5. doi: 10.1001/jama.276.3.211. JAMA. 1996. PMID: 8667565
Among athletes, left ventricular cavity dimension was 40 mm to 66 mm, exceeded normal limits ( > 54 mm) in 47 women (8%), and was within the range consistent with primary dilated cardiomyopathy ( > or = 60 mm) in 4 athletes (1%). ...
Among athletes, left ventricular cavity dimension was 40 mm to 66 mm, exceeded normal limits ( > 54 mm) in 47 women (8%), and was within …
23 results